Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMISH: Irbesartan vs Amlodipine in Elderly ISH
NCT00264212Phase 4Completed
- Sponsor
- Sanofi
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 4, randomised, open-label trial of irbesartan in isolated systolic hypertension (ISH) (2 arms), sponsored by Sanofi. Primary endpoint: Change from baseline in office seated Systolic Blood Pressure at 12 weeks. Started Aug 2004; status: completed.
02
Drugs
irbesartan
03
Conditions
isolated systolic hypertension (ISH)
Beyond the preview
Go deeper on NCT00264212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00264212.